NO940580D0 - Procedure for lowering blood lipid levels - Google Patents

Procedure for lowering blood lipid levels

Info

Publication number
NO940580D0
NO940580D0 NO940580A NO940580A NO940580D0 NO 940580 D0 NO940580 D0 NO 940580D0 NO 940580 A NO940580 A NO 940580A NO 940580 A NO940580 A NO 940580A NO 940580 D0 NO940580 D0 NO 940580D0
Authority
NO
Norway
Prior art keywords
procedure
blood lipid
lowering blood
lipid levels
levels
Prior art date
Application number
NO940580A
Other languages
Norwegian (no)
Other versions
NO940580L (en
Inventor
Georges H Van Der Berghe
Harry Edward Gruber
Original Assignee
Gensia Inc
Gensia Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gensia Inc, Gensia Pharma filed Critical Gensia Inc
Publication of NO940580D0 publication Critical patent/NO940580D0/en
Publication of NO940580L publication Critical patent/NO940580L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO940580A 1991-08-23 1994-02-21 Procedure for lowering blood lipid levels NO940580L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74894491A 1991-08-23 1991-08-23
US92975292A 1992-08-12 1992-08-12
PCT/US1992/006828 WO1993003734A1 (en) 1991-08-23 1992-08-14 Method for lowering blood lipid levels

Publications (2)

Publication Number Publication Date
NO940580D0 true NO940580D0 (en) 1994-02-21
NO940580L NO940580L (en) 1994-04-25

Family

ID=27115023

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940580A NO940580L (en) 1991-08-23 1994-02-21 Procedure for lowering blood lipid levels

Country Status (7)

Country Link
EP (1) EP0599987A4 (en)
AU (1) AU2486192A (en)
CA (1) CA2115675A1 (en)
IL (1) IL102895A0 (en)
MX (1) MX9204880A (en)
NO (1) NO940580L (en)
WO (1) WO1993003734A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050002943A1 (en) * 2001-10-31 2005-01-06 Oberdan Leo Amp-kinase agonists or adenosine pro-drugs as immuno-stimulating agents
ES2192495B1 (en) 2002-03-21 2005-02-16 Universidad De Barcelona NEW THERAPEUTIC USE OF RIBOSIDE 5-AMINOIMIDAZOL-4-CARBOXAMIDE (ACADESIN).
US8895520B2 (en) 2011-10-26 2014-11-25 Universite Nice Sophia Antipolis Method for treating a human patent suffering from Myeloid Neoplasias using 5-aminoimidazole-4-carboxamide
MY182801A (en) * 2013-09-26 2021-02-05 Energenesis Biomedical Co Ltd Compound for activating ampk and uses thereof
CA3107170A1 (en) 2018-08-06 2020-03-12 Skylark Bioscience Llc Amp-activated protein kinase activating compounds and uses thereof
US11779590B2 (en) 2020-10-30 2023-10-10 Skylark Bioscience Llc AMP-activated protein kinase activating compounds and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2026040C3 (en) * 1970-05-27 1975-09-18 Boehringer Mannheim Gmbh, 6800 Mannheim Imidazole ribosylcyclophosphate
US3919192A (en) * 1972-05-22 1975-11-11 Icn Pharmaceuticals 5-Amino-4-substituted imidazole nucleotides
US4575498A (en) * 1983-07-21 1986-03-11 Duke University Method for restoring depleted purine nucleotide pools
US4912092A (en) * 1986-03-27 1990-03-27 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells

Also Published As

Publication number Publication date
WO1993003734A1 (en) 1993-03-04
IL102895A0 (en) 1993-01-31
EP0599987A4 (en) 1995-02-01
CA2115675A1 (en) 1993-03-04
AU2486192A (en) 1993-03-16
MX9204880A (en) 1993-04-01
NO940580L (en) 1994-04-25
EP0599987A1 (en) 1994-06-08

Similar Documents

Publication Publication Date Title
DK0547901T3 (en) Lifts for patients
FI923273A (en) MEDICAL DOUBLE FOERSETT MULTIPROCESSORSYSTEM
DE69211359D1 (en) BLOOD TANK
DE69217375T2 (en) Determination procedure
ITMI921590A0 (en) THIEMETHYLATED BENZOFURAN-2-ONES
DE69220862T2 (en) mattress
DE69215639D1 (en) endoscope
FI942972A0 (en) Recessed bed or bed blood structure
NO914995D0 (en) FULLY Wheelchair accessible
NO940580D0 (en) Procedure for lowering blood lipid levels
NO924040L (en) WHEELCHAIR
NO954147L (en) Improvements regarding patient lifts
ATA151691A (en) MEDICAL ELEVATOR
DK56591D0 (en) TOURNESS PROCEDURES
KR950022790U (en) Medical bedding
NO922488L (en) WHEELCHAIR
KR930006241U (en) Patient
KR950003044U (en) Patient bed
KR950016714U (en) Patient bed
ES1018174Y (en) CLINICAL BED.
KR930002179U (en) Foot pillow
KR930000941U (en) Boltless Hocha
NO940377L (en) Wheelchair
NO913425L (en) WHEELCHAIR
SE9102036D0 (en) PROCEDURES FOR RIPLESS REDUCTION